Annual Non Current Assets
$56.39 M
+$4.18 M+8.01%
December 31, 2022
Summary
- As of February 8, 2025, AMAM annual long term assets is $56.39 million, with the most recent change of +$4.18 million (+8.01%) on December 31, 2022.
- During the last 3 years, AMAM annual non current assets has risen by +$12.82 million (+29.43%).
Performance
AMAM Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Non Current Assets
$37.68 M
-$849.00 K-2.20%
September 1, 2023
Summary
- As of February 8, 2025, AMAM quarterly long term assets is $37.68 million, with the most recent change of -$849.00 thousand (-2.20%) on September 1, 2023.
Performance
AMAM Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
AMAM Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.0% | - |
| 3 y3 years | +29.4% | -8.0% |
| 5 y5 years | +29.4% | - |
AMAM Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -7.4% | -37.1% | at low |
| 5 y | 5-year | at high | -27.4% | -37.1% | at low |
| alltime | all time | at high | -27.4% | -37.1% | at low |
Ambrx Biopharma Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $37.68 M(-2.2%) |
| Jun 2023 | - | $38.53 M(-19.2%) |
| Mar 2023 | - | $47.67 M(-15.5%) |
| Dec 2022 | $90.58 M(-48.8%) | $56.39 M(-5.8%) |
| Jun 2022 | - | $59.86 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $176.81 M(+90.0%) | - |
| Dec 2021 | - | $52.21 M(+28.3%) |
| Jun 2021 | - | $40.70 M(-0.6%) |
| Dec 2020 | $93.08 M(+412.6%) | - |
| Dec 2020 | - | $40.94 M |
| Dec 2019 | $18.16 M | - |
FAQ
- What is Ambrx Biopharma annual long term assets?
- What is the all time high annual non current assets for Ambrx Biopharma?
- What is Ambrx Biopharma annual non current assets year-on-year change?
- What is Ambrx Biopharma quarterly long term assets?
- What is the all time high quarterly non current assets for Ambrx Biopharma?
What is Ambrx Biopharma annual long term assets?
The current annual non current assets of AMAM is $56.39 M
What is the all time high annual non current assets for Ambrx Biopharma?
Ambrx Biopharma all-time high annual long term assets is $56.39 M
What is Ambrx Biopharma annual non current assets year-on-year change?
Over the past year, AMAM annual long term assets has changed by +$4.18 M (+8.01%)
What is Ambrx Biopharma quarterly long term assets?
The current quarterly non current assets of AMAM is $37.68 M
What is the all time high quarterly non current assets for Ambrx Biopharma?
Ambrx Biopharma all-time high quarterly long term assets is $59.86 M